Merck Healthcare Kgaa, Darmstadt, Germany, An Affiliate Of Merck Kgaa, Darmstadt, Germany

This study is testing a new pill form of a drug called cladribine to see if it can help control symptoms of generalized myasthenia gravis (gMG), a disease that causes severe muscle weakness. Researchers will compare the drug to a placebo in about 264 adults with moderate to sever…

This study is testing whether a new combination of two fertility hormones works better and is as safe as the standard treatment for Japanese women who lack specific hormones needed for egg development. About 333 women who need help getting pregnant through IVF will receive either…

This is an early-stage study to check the safety of a new drug called M5542 when given as an injection to healthy people. Researchers will give different doses to small groups of participants and closely monitor for any side effects. The main goal is to see how the body handles t…

This early-stage study aims to understand how kidney function affects the way a new drug called enpatoran moves through the body. Researchers will compare a single dose in 40 people with normal kidney function to those with impaired kidney function. The main goal is to measure dr…